Take Your Trading To The Next Level. Get Started Here!

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

December 6, 2023 Comments Off

The deal is AbbVie’s latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.